PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 134 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 283 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  2. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  3. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  4. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  5. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  6. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  7. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  8. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  9. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  10. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  11. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  12. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  13. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  14. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  15. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  16. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  17. Gawish R, et al. 2022. Elife. 11:. PubMed
  18. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  19. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  20. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  21. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  22. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  23. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  24. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  25. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  26. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  27. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  28. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  29. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  30. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  31. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  32. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  33. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  34. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  35. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  36. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  37. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  38. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  39. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  40. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  41. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  42. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  43. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  44. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  45. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  46. Sun P, et al. 2015. J Hepatol. . PubMed
  47. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  48. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  49. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  50. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  51. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  52. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  53. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  54. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  55. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  56. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  57. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  58. Morales D, et al. 2015. J Virol. 89:337. PubMed
  59. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  60. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  61. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  62. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  63. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  64. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  65. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  66. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  67. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  68. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  69. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  70. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  71. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  72. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  73. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  74. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  75. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  76. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  77. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  78. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  79. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  80. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  81. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  82. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  83. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  84. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  85. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  86. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  87. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  88. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  89. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  90. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  91. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  92. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  93. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  94. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  95. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  96. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  97. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  98. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  99. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  100. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  101. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  102. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  103. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  104. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  105. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  106. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  107. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  108. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  109. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  110. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  111. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  112. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  113. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  114. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  115. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  116. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  117. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  118. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  119. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  120. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  121. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  122. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  123. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  124. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  125. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  126. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  127. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  128. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  129. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  130. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  131. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  132. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  133. Kim M, et al. 2018. Immunity. 49:151. PubMed
  134. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  135. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  136. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  137. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  138. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  139. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  140. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  141. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  142. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  143. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  144. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  145. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  146. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  147. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  148. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  149. Issah Y, et al. 2021. Elife. 10:. PubMed
  150. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  151. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  152. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  153. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  154. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  155. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  156. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  157. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  158. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  159. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  160. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  161. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  162. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  163. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  164. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  165. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  166. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  167. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  168. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  169. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  170. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  171. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  172. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  173. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  174. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  175. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  176. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  177. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  178. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  179. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  180. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  181. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  182. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  183. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  184. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  185. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  186. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  187. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  188. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  189. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  190. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  191. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  192. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  193. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  194. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  195. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  196. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  197. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  198. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  199. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  200. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  201. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01.06.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account